Soltis Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
132,646
+8,114
+7% +$655K 0.58% 40
2026
Q1
$10.8M Buy
124,532
+22,505
+22% +$2.16M 0.68% 25
2025
Q4
$9.8M Buy
102,027
+4,637
+5% +$450K 0.65% 26
2025
Q3
$9.28M Buy
97,390
+4,168
+4% +$383K 0.64% 31
2025
Q2
$8.13M Buy
93,222
+4,687
+5% +$397K 0.64% 32
2025
Q1
$7.96M Buy
88,535
+2,336
+3% +$209K 0.71% 30
2024
Q4
$6.89M Sell
86,199
-1,911
-2% -$165K 0.64% 34
2024
Q3
$7.93M Buy
88,110
+20,352
+30% +$1.71M 0.78% 27
2024
Q2
$5.33M Buy
67,758
+697
+1% +$57.1K 0.56% 53
2024
Q1
$5.84M Sell
67,061
-4,923
-7% -$420K 0.65% 44
2023
Q4
$5.93M Sell
71,984
-94
-0.1% -$7.16K 0.67% 43
2023
Q3
$5.65M Buy
72,078
+3,497
+5% +$293K 0.73% 36
2023
Q2
$6.04M Buy
68,581
+3,128
+5% +$269K 0.7% 31
2023
Q1
$5.28M Buy
65,453
+14,616
+29% +$1.19M 0.67% 37
2022
Q4
$3.95M Buy
50,837
+43,624
+605% +$3.54M 0.52% 55
2022
Q3
$582K Sell
7,213
-95
-1% -$8.54K 0.09% 151
2022
Q2
$656K Buy
7,308
+24
+0.3% +$2.43K 0.1% 148
2022
Q1
$808K Buy
7,284
+2,479
+52% +$262K 0.11% 138
2021
Q4
$497K Buy
4,805
+13
+0.3% +$1.5K 0.07% 168
2021
Q3
$601K Buy
4,792
+29
+0.6% +$3.75K 0.09% 149
2021
Q2
$591K Sell
4,763
-503
-10% -$63.2K 0.09% 152
2021
Q1
$622K Sell
5,266
-1,244
-19% -$146K 0.11% 131
2020
Q4
$763K Buy
+6,510
New +$717K 0.14% 114

Other funds holding MDT

Soltis Investment Advisors's MDT Position: Q2 2026 in Review

Soltis Investment Advisors increased its Medtronic (MDT) stake by 6.5% in Q2 2026, buying an estimated $655K and bringing the position to 132,646 shares worth $10.4M. The position accounts for 0.58% of the portfolio, ranked #40.

Soltis Investment Advisors first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.8M in Q1 2026. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Soltis Investment Advisors held 132,646 shares of Medtronic worth $10.4M as of Q2 2026.
  • Soltis Investment Advisors bought 8,114 Medtronic shares in Q2 2026, an estimated $655K.
  • Medtronic made up 0.58% of Soltis Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • Soltis Investment Advisors first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
  • Soltis Investment Advisors's Medtronic position peaked at $10.8M in Q1 2026.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.